Advertisement
Free access | 10.1172/JCI110205
Department of Chemical Pathology and Metabolic Disorders, St. Thomas' Hospital Medical School, London, SE1 7EH England
Department of Cardiology, St. Thomas' Hospital Medical School, London, SE1 7EH England
Find articles by Turner, P. in: JCI | PubMed | Google Scholar
Department of Chemical Pathology and Metabolic Disorders, St. Thomas' Hospital Medical School, London, SE1 7EH England
Department of Cardiology, St. Thomas' Hospital Medical School, London, SE1 7EH England
Find articles by Miller, N. in: JCI | PubMed | Google Scholar
Department of Chemical Pathology and Metabolic Disorders, St. Thomas' Hospital Medical School, London, SE1 7EH England
Department of Cardiology, St. Thomas' Hospital Medical School, London, SE1 7EH England
Find articles by Cortese, C. in: JCI | PubMed | Google Scholar
Department of Chemical Pathology and Metabolic Disorders, St. Thomas' Hospital Medical School, London, SE1 7EH England
Department of Cardiology, St. Thomas' Hospital Medical School, London, SE1 7EH England
Find articles by Hazzard, W. in: JCI | PubMed | Google Scholar
Department of Chemical Pathology and Metabolic Disorders, St. Thomas' Hospital Medical School, London, SE1 7EH England
Department of Cardiology, St. Thomas' Hospital Medical School, London, SE1 7EH England
Find articles by Coltart, J. in: JCI | PubMed | Google Scholar
Department of Chemical Pathology and Metabolic Disorders, St. Thomas' Hospital Medical School, London, SE1 7EH England
Department of Cardiology, St. Thomas' Hospital Medical School, London, SE1 7EH England
Find articles by Lewis, B. in: JCI | PubMed | Google Scholar
Published June 1, 1981 - More info
The metabolism of apoprotein B-containing plasma lipoproteins by human splanchnic tissues has been studied in 29 men undergoing coronary angiography. Before catheterization autologous radio-iodinated lipoproteins were infused into a peripheral vein: 10 subjects received 125I-labeled Sf 12-60 lipoproteins; 12 received 125I-labeled Sf 12-60 plus 131I-labeled Sf 100-400 lipoproteins; and 7 received 125I-labeled Sf 12-60 plus 131I-labeled Sf 0-12 lipoproteins. Paired arterial and hepatic vein blood samples were subsequently collected for replicate measurements of apoprotein B (apo B) mass, radioactivity and specific activity in each lipoprotein class. Splanchnic plasma flow was measured with indocyanine green. All studies were conducted after a 14-h overnight fast.
Newly synthesized apo B was shown to be secreted by splanchnic tissues as a component of Sf 100-400 lipoproteins, with no detectable uptake of apo B from this class. Sf 12-60 apo B was extracted by the splanchnic bed, with no detectable secretion. After continuous intravenous infusion of 125I-labeled Sf 12-60 for five or more hours, 41-67% (mean 55%) of extracted Sf 12-60 apo B radioactivity reappeared in hepatic vein Sf 0-12 apo B. There was no detectable splanchnic catabolism of Sf 0-12 apo B.
The rates of Sf 100-400 apo B secretion, calculated as the product of artery-hepatic vein concentration difference and splanchnic plasma flow, were greater than the previously reported rates of very low density lipoprotein apo B turnover in fed subjects obtained by kinetic analysis of plasma specific radioactivity decay curves, suggesting that there may be a diurnal variation in hepatic apo B synthesis. They also exceeded the splanchnic extraction rates of Sf 12-60 apo B, suggesting there was some extrasplanchnic catabolism of the apo B of Sf > 60 lipoproteins.